Citation: | YANG Youtian, MAO Baiyang, CHENG Lifei, SU Mengxiang, DI Bin. Identification of the related substances in telmisartan/amlodipine double layer tablets by LC-MS/MS[J]. Journal of China Pharmaceutical University, 2014, 45(1): 65-69. DOI: 10.11665/j.issn.1000-5048.20140111 |
[1] |
Xu GQ,Li W,Hao EJ.Graphical synthetic routes of telmisartan[J].Chin J Pharm(中国医药工业杂志),2009,40(9):714-715.
|
[2] |
Yuan LL.Comparison of telmisartan therapy with amlodipine in the treatment of patients with mild and moderate hypertension:randomized,double blind,parallel-controlled[J].Mod Med J(现代医学),2012,40(1):35-38.
|
[3] |
Suárez C.Single-pill telmisartan and amlodipine:a rational combination for the treatment of hypertension[J].Drugs,2011,71(17):2 295-2 305.
|
[4] |
The United States Pharmacopeial Convention.U.S.Pharmacopeia[M].35 ed.Baltimore:United Book Press,Inc,2012.
|
[5] |
The British Pharmacopoeia Commission.The British Pharmacopoeia 2010[M].London:the Station Office,2009.
|
[6] |
Ding XQ,Chao RB,Liao L,et al.Determination of telmisartan and its related substances by HPLC[J].West China J Pharm Sci(华西药学杂志),2003,18(3):212-214.
|
[7] |
Wang B, Chen W, Yin XZ. Determination of the related substances in compound telmisartan tablets by RP-HPLC gradient elution method[J].Guangdong Chem Ind(广东化工),2010,37(12):227-228.
|
[8] |
Xiao SJ,Yang XY,Wu FH,et al.Synthesis of the antihypertensive drug telmisartan[J].Chin J New Drugs(中国新药杂志),2010,19(18):1 726-1 728.
|
[1] | WANG Lei, MA Jun, GU Mengyue, DI Rongrong, LIU Yu, LAI Yisheng. Design, synthesis and biological evaluation of five-membered heterocyclopyrimidines as MTH1 inhibitors[J]. Journal of China Pharmaceutical University, 2018, 49(4): 407-412. DOI: 10.11665/j.issn.1000-5048.20180404 |
[2] | JIN Shuanglong, WANG Fang, ZOU Yi, WANG Yan, HU Yue, GUO Wenjie, XU Qiang, LAI Yisheng. Design, synthesis and biological evaluation of phenylsulfonamide-based IDO1 inhibitors[J]. Journal of China Pharmaceutical University, 2018, 49(1): 34-38. DOI: 10.11665/j.issn.1000-5048.20180105 |
[3] | ZHU Bao, JIN Shuanglong, GUO Yi, LI Yuezhen, ZHANG Yihua, LAI Yisheng. Design, synthesis and biological evaluation of pyridine-based IRAK4 inhibitors[J]. Journal of China Pharmaceutical University, 2017, 48(6): 670-674. DOI: 10.11665/j.issn.1000-5048.20170606 |
[4] | MAO Zewei, WAN Chunping, ZHENG Xi, JIANG Yuan, RAO Gaoxiong. Synthesis and biological activities of novel hybrid compounds based on piperazines and acetophenones[J]. Journal of China Pharmaceutical University, 2014, 45(5): 517-521. DOI: 10.11665/j.issn.1000-5048.20140502 |
[5] | JIANG Neng, JIANG Jian-qin, SHEN Jian-hua. Design,synthesis and in vitro activity of quinazolone glycine transporter-1 inhibitors[J]. Journal of China Pharmaceutical University, 2012, 43(3): 199-203. |
[6] | LI Tai-ming, MA Yan-hong, XU Shu, LIU Tao, GU Chun-jiao, XU Chen, LIU Jing-jing. Preparation and preliminary analysis of activity of recombinant GLP-1 analogue[J]. Journal of China Pharmaceutical University, 2011, 42(6): 560-564. |
[7] | Studies on Dimensional Structure and Biological Activity of Flammulina velutipes Polysaccharides Containing Germanium[J]. Journal of China Pharmaceutical University, 2004, (6): 95-99. |
[8] | Synthesis and Bio activity of Benzimidazole 2 Acyl Compounds[J]. Journal of China Pharmaceutical University, 1998, (4): 3-6. |
[9] | ISOLATION, ANALYSIS AND BIOLOGICAL ACTIVITIES OF SODIUM ALGINATE[J]. Journal of China Pharmaceutical University, 1988, (4): 279-281. |
[10] | PREPARATION, ANALYSIS AND BIOLOGICAL ACTIVITIES OF LAMINARIN AND LAMINARIN SULFATE[J]. Journal of China Pharmaceutical University, 1988, (1): 30-34. |